Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era.
Richard J StrakerYun SongJames SunAdrienne B ShannonLeah S CohenElnara MuradovaHala DaouKate KrauseSiming LiDennie T FrederickKristen E RhodinDavid M BrizelGenevieve M BolandGeorgia M BeasleyEvan J WuthrickVernon K SondakJonathan S ZagerAlexander LinJohn N LukensGiorgos C KarakousisPublished in: Annals of surgical oncology (2020)
In the era of modern ST, RT may still have value in reducing LNB recurrences in melanoma with clinical LN metastases. Further research should focus on whether select patient populations derive benefit from combination therapy, and optimizing indications for RT following neoadjuvant ST.